How do the clinical effects and response times of dupilumab, omalizumab, and mepolizumab compare when treating patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP)?
Are New Biologics a Game Changer for Treating Nasal Polyposis?
Reboot Approach Significantly Reduces Post-Op Nasal Polyp Recurrence
The reboot approach significantly reduced nasal polyp recurrence for 30 months postoperatively compared to the current mucosa-sparing approach.
Biologics for Chronic Rhinosinusitis and Nasal Polyposis
Steroid-Eluting Implants Effective for Recurrent Nasal Polyps
Can the use of steroid eluting stents play a positive role in treating post-surgery recurrent nasal polyposis in the clinic?